Income Before Tax
Pre-Tax Income
Bristol-Myers Squibb Pre-Tax Income increased by 75.6% to $3.11B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 85.8%, from $1.68B to $3.11B. Over 3 years (FY 2021 to FY 2024), Pre-Tax Income shows a downward trend with a 1.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
Detailed definition
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Peer comparison
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
Metric ID:
is_income_before_taxHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.55B | $2.16B | $1.86B | $1.69B | $1.96B | $2.21B | $1.86B | $2.77B | $1.86B | $2.14B | $1.67B | -$11.52B | $1.29B | $1.68B | $0.00 | $2.97B | $1.77B | $3.11B |
| QoQ Change | — | +38.9% | -13.9% | -9.2% | +16.1% | +12.8% | -15.8% | +49.0% | -32.9% | +15.0% | -21.7% | -787.9% | +111.2% | +30.3% | -100.0% | — | -40.3% | +75.6% |
| YoY Change | — | — | — | — | +26.1% | +2.4% | +0.1% | +64.2% | -5.1% | -3.3% | -10.0% | -515.7% | -30.8% | -21.6% | -100.0% | +125.8% | +37.9% | +85.8% |
Range-$11.52B – $3.11B
CAGR+17.8%
Avg YoY Growth-24.6%
Median YoY Growth-1.6%
Pre-Tax Income at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's pre-tax income?
- Bristol-Myers Squibb (BMY) reported pre-tax income of $3.11B in Q3 2025.
- How has Bristol-Myers Squibb's pre-tax income changed year-over-year?
- Bristol-Myers Squibb's pre-tax income increased by 85.8% year-over-year, from $1.68B to $3.11B.
- What is the long-term trend for Bristol-Myers Squibb's pre-tax income?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's pre-tax income has grown at a 1.8% compound annual growth rate (CAGR), from $8.10B to -$8.55B.
- What does pre-tax income mean?
- The total profit a company made before paying its income taxes.